Literature DB >> 30455229

Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections.

Werner Zimmerli1,2, Parham Sendi3,4.   

Abstract

Rifampin has been used as an agent in combination therapy in orthopedic device-related infections (ODRI) for almost three decades. The aim of this review is to provide data regarding the role of rifampin against biofilm infection in vitro, in animal models, and in clinical ODRI. Available data are gathered in order to present the rational use of rifampin combinations in patients with periprosthetic joint infection (PJI). The role of rifampin is well defined in patients with PJI and is indicated in those who fulfill the Infectious Diseases Society of America criteria for debridement and implant retention or one-stage exchange. It should be used with care because of the danger of rapid emergence of resistance. Potential drug interactions should be considered.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Staphylococcuszzm321990; prosthetic joint infection; rifampin

Mesh：

Substances：

Year:  2019        PMID： 30455229      PMCID： PMC6355554          DOI： 10.1128/AAC.01746-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  98 in total

Review 1.  Antibiotic resistance of bacteria in biofilms.

Authors:  P S Stewart; J W Costerton
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

Review 2.  Prosthetic-joint infections.

Authors:  Werner Zimmerli; Andrej Trampuz; Peter E Ochsner
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

3.  Clinical outcome and risk factors for failure in late acute prosthetic joint infections treated with debridement and implant retention.

Authors:  Marjan Wouthuyzen-Bakker; Marine Sebillotte; Jose Lomas; Adrian Taylor; Eva Benavent Palomares; Oscar Murillo; Javad Parvizi; Noam Shohat; Javier Cobo Reinoso; Rosa Escudero Sánchez; Marta Fernandez-Sampedro; Eric Senneville; Kaisa Huotari; José Maria Barbero; Joaquín Garcia-Cañete; Jaime Lora-Tamayo; Matteo Carlo Ferrari; Danguole Vaznaisiene; Erlangga Yusuf; Craig Aboltins; Rihard Trebse; Mauro José Salles; Natividad Benito; Andrea Vila; Maria Dolores Del Toro; Tobias Siegfried Kramer; Sabine Petersdorf; Vicens Diaz-Brito; Zeliha Kocak Tufan; Marisa Sanchez; Cédric Arvieux; Alex Soriano
Journal:  J Infect       Date:  2018-08-07       Impact factor: 6.072

4.  Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.

Authors:  W Zimmerli; A F Widmer; M Blatter; R Frei; P E Ochsner
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

5.  Efficacy of a combined oral clindamycin?rifampicin regimen for therapy of staphylococcal osteoarticular infections.

Authors:  Jaroslaw Czekaj; Aurélien Dinh; Andreea Moldovan; Pierre Vaudaux; Guillaume Gras; Pierre Hoffmeyer; Daniel Lew; Louis Bernard; Ilker Uçkay
Journal:  Scand J Infect Dis       Date:  2011-09-15

6.  Antifungal activity against planktonic and biofilm Candida albicans in an experimental model of foreign-body infection.

Authors:  Elena Maryka Maiolo; Alessandra Oliva; Ulrika Furustrand Tafin; Nancy Perrotet; Olivier Borens; Andrej Trampuz
Journal:  J Infect       Date:  2015-12-24       Impact factor: 6.072

7.  Evaluation of MBEC™-HTP biofilm model for studies of implant associated infections.

Authors:  Debora C Coraça-Hubér; Manfred Fille; Johann Hausdorfer; Kristian Pfaller; Michael Nogler
Journal:  J Orthop Res       Date:  2012-01-06       Impact factor: 3.494

8.  Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model.

Authors:  Ulrika Furustrand Tafin; Stéphane Corvec; Bertrand Betrisey; Werner Zimmerli; Andrej Trampuz
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

9.  Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement.

Authors:  F Vilchez; J C Martínez-Pastor; S García-Ramiro; G Bori; F Maculé; J Sierra; L Font; J Mensa; A Soriano
Journal:  Clin Microbiol Infect       Date:  2011-03       Impact factor: 8.067

10.  Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study.

Authors:  Felix Greimel; Christine Scheuerer; Andre Gessner; Michaela Simon; Thomas Kalteis; Joachim Grifka; Achim Benditz; Hans-Robert Springorum; Jens Schaumburger
Journal:  Drug Des Devel Ther       Date:  2017-06-14       Impact factor: 4.162
View more
  39 in total

Review 1.  Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype.

Authors:  Kelly M Craft; Johny M Nguyen; Lawrence J Berg; Steven D Townsend
Journal:  Medchemcomm       Date:  2019-03-14       Impact factor: 3.597

2.  Dual Drug Loaded pH-sensitive Micelles for Efficient Bacterial Infection Treatment.

Authors:  Yingxian Chen; Qian Zhao; Junhua Han; Xinmiao Lan; Jing Che; Meiwan Chen; Xing-Jie Liang; Xiaowei Ma
Journal:  Pharm Res       Date:  2022-02-14       Impact factor: 4.200

Review 3.  [Management of fracture-related infections].

Authors:  Jan-Dierk Clausen; Philipp Mommsen; Tarek Omar Pacha; Marcel Winkelmann; Christian Krettek; Mohamed Omar
Journal:  Unfallchirurg       Date:  2021-12-21       Impact factor: 1.000

Review 4.  Rifamycin antibiotics and the mechanisms of their failure.

Authors:  Rebekah A Adams; Gabrielle Leon; Natalia M Miller; Saira P Reyes; Chantal H Thantrong; Alina M Thokkadam; Annabel S Lemma; Darshan M Sivaloganathan; Xuanqing Wan; Mark P Brynildsen
Journal:  J Antibiot (Tokyo)       Date:  2021-08-16       Impact factor: 2.649

5.  Adjunctive Rifampicin Increases Antibiotic Efficacy in Group A Streptococcal Tissue Infection Models.

Authors:  H Bergsten; L M Palma Medina; M Morgan; K Moll; D H Skutlaberg; S Skrede; T Wajima; M Svensson; A Norrby-Teglund
Journal:  Antimicrob Agents Chemother       Date:  2021-09-07       Impact factor: 5.191

6.  Direct Intra-articular Antibiotic Administration for Acute Prosthetic Joint Infection in Knee Arthroplasty.

Authors:  Wan Lye Cheong; Yi Xiang Tan; Teck Siong Fong; Mohamed Nazri Mohamed Nazeeb; Tuck Shin Fong
Journal:  Cureus       Date:  2022-07-06

7.  Halicin Is Effective Against Staphylococcus aureus Biofilms In Vitro.

Authors:  Shota Higashihira; Stefanie Jan Simpson; Christopher David Collier; Roman Michael Natoli; Mizuho Kittaka; Edward Michael Greenfield
Journal:  Clin Orthop Relat Res       Date:  2022-05-17       Impact factor: 4.755

8.  Estimation of Minimum Biofilm Eradication Concentration (MBEC) on In Vivo Biofilm on Orthopedic Implants in a Rodent Femoral Infection Model.

Authors:  Yu Okae; Kohei Nishitani; Akio Sakamoto; Toshiyuki Kawai; Takuya Tomizawa; Motoo Saito; Yutaka Kuroda; Shuichi Matsuda
Journal:  Front Cell Infect Microbiol       Date:  2022-07-01       Impact factor: 6.073

Review 9.  Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies.

Authors:  Katrin Schilcher; Alexander R Horswill
Journal:  Microbiol Mol Biol Rev       Date:  2020-08-12       Impact factor: 11.056

Review 10.  When One Drug Is Not Enough: Context, Methodology, and Future Prospects in Antibacterial Synergy Testing.

Authors:  Thea Brennan-Krohn; James E Kirby
Journal:  Clin Lab Med       Date:  2019-06-12       Impact factor: 1.935
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.